The comparative efficacy between the conventional vaccine (DLS-DPV) and experimentally prepared duck plague vaccine (BAU-DPV) was evaluated in seventy-five 35-day-old Zinding breed ducklings during the period from October/02 to March/03. The ducklings were equally divided into five groups (A, B, C, D and E). Ducklings of group A and B were primarily vaccinated with 0.5 ml and 1.0 ml of DLS-DPV respectively and those of group C and D were primarily vaccinated with 0.5 ml and 1.0 ml of BAU-DPV. The ducklings of group E were kept as unvaccinated control. Five months after primary vaccination all the ducks of vaccinated groups were boosted with 1.0 ml of DLS-DPV and BAU-DPV and 21 days after booster vaccination all the ducks of vaccinated and control groups were challenged with 1ml of 10 EID of virulent 4 50 field isolate of duck plague virus (DPV). The level of immunity developed in different vaccinated groups of ducks was measured by passive hemagglutination (PHA) test. The mean PHA titre of birds of group A, B, C and D after primary vaccination were 38.4 ± 6.4, 28.8 ± 3.2, 51.2 ± 7.84 and 38.4 ± 6.4 and after booster vaccination were 153.6 ± 25.6, 76.8 ± 12.8, 358.4 ± 62.71 and 115.2 ± 12.8 respectively. Results of PHA test indicated that experimentally prepared duck plague (BAU-DPV) vaccine revealed higher immune response compared to that of the conventional (DLS-DPV) vaccine and results of the challenge experiment indicated that the mean PHA titre over 100 after booster vaccination revealed 100% protection.
Introduction
Ducks are considered as relatively resistant birds compared to the other members of domestic poultry. Although some viral and bacterial diseases seriously
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attack the ducks and cause havoc. Among the prevailing
The local virulent duck plague virus (DPV) isolate was infectious diseases of ducks in Bangladesh, duck obtained from the laboratory repository of the plague (DP) is considered to be the highly infectious as Department of Microbiology and Hygiene, BAU, well as contagious disease causing mortality of 60-70%
Mymensingh and was used as stock virus for the (Sarkar, 1982) . The infection is due to duck plague experimental production of duck plague vaccine (BAUvirus under the family herpesviridae which i s DPV). The conventional vaccine (DLS-DPV) produced by characterized by high morbidity and mortality varying the Directorate of Livestock Service (DLS) at the from 5-100% (Calnek et al., 1997) . This disease Livestock Research Institute (LRI), Mohakhali, Dhaka, occurs every year in Bangladesh in epidemic form and Bangladesh was collected. Fertile eggs of both ducks spreads rapidly among the duck raising areas. The and chicken were purchased from the Bangladesh vaccine produced by Directorate of Livestock Service Agricultural University (BAU) Poultry farm throughout the known as (DLS-DPV) is reported to provide good experiment. A total of 75 Zinding breed ducklings of 35-immunity but sometimes fails to protect the ducks day-old were purchased from the Government Poultry despite regular vaccination. This might happen due to Farm, Kishoregonj and were rared during the whole inadequate relationship between the vaccine strain and period of study. the prevailing strain of duck plague virus or some other reasons in field condition. If the confidence among the Experimental preparation of BAU-DPV vaccine: BAUexisting small and landless farmers be created b y DPV vaccine was prepared with a local virulent isolate of reducing the high rate of morbidity and mortality of their DPV by attenuating the virus in embryonated chicken ducks, there would be significant increase of production eggs. Before attenuation, the DPV was serially of duck eggs. This study was conducted for the passaged in embryonated duck eggs of 10-day-old upto preparation of experimental duck plague vaccine with a 5 passage. The duck embryo adapted DPV isolate was local isolate of Bangladesh and to study the comparative then attenuated by passage in the 11-day-old efficacy between conventional vaccine (DLS-DPV) and experimental prepared duck plague vaccine (BAU-DPV).
th 1988). Ducklings receiving 15th passaged material with During primary vaccination, the ducklings of group A and virus titre of 10 EID /ml showed 100% protection (John B were vaccinated with 0.5ml and 1.0 ml of DLS-DPV et al., 1990) . For that reason virulent duck plague virus vaccine and the ducklings of group C and D were was attenuated up to 16 passages in chicken embryo for vaccinated with 0.5 ml and 1.0 ml of BAU-DPV vaccine experimental preparation of vaccine (BAU-DPV vaccine). while group E was kept as unvaccinated control. During
The mean PHA titres of ducklings of group A, B, C and D booster vaccination all the groups of ducklings were were 38.4 ± 6.4, 28.8 ± 3.2, 51.2 ± 7.84 and 38.4 ± 6.4 vaccinated with 1.0 ml of the vaccines i.e. group A and B respectively after primary vaccination and the mean PHA were vaccinated with DLS-DPV vaccine and group C and titres of ducks of group A, B, C and D after booster D were vaccinated with BAU-DPV vaccine.
vaccination were 153.6 ± 25.6, 76.8 ± 12.8, 358 .4 ± Passive hemagglutination (PHA) test: Comparative Revaccinated ducks produced higher degree o f efficacy of both the vaccines were studied by passive protection when challenged with virulent duck plague hemagglutination (PHA) test as per method described virus (Toth, 1971) . In this study, all the experimental by Zyambo et al. (1973) and with some modifications of ducks were revaccinated at 5 months after primary the method described by Tripathy et al. (1970) . vaccination with 1.0 ml. of DLS-DPV and BAU-DPV Protection test: 21 days after booster vaccination all except that of group B gave 100% protection against ducks of vaccinated and control groups were challenged challenge infection with DP virus (Table 2) . with 1ml of 10 EID of virulent field isolate of DPV.
In this study it is observed that the mean PHA titre 4 50
Protection test was performed as per the method increased gradually. The highest mean PAH titre is 51.2 described by Reed and Muench (1938) . ± 7.84 at primary vaccination followed by 358.4 ± 62.71
Results and Discussion
Experimentally prepared duck plague vaccine (BAU-DPV) was prepared after giving 16 passages of local isolate of virulent duck plague virus in 11-day-old chicken were resistant to virulent challenge (Jansen and Kunst, 3.5 50 62.71 and 115.2 ± 12.8 respectively (Table 1) .
vaccine. After booster vaccination all groups of ducks at booster vaccination. Ducklings of all the groups vaccinated with DLS-DPV or BAU-DPV vaccines gave good result. But ducklings of group C vaccinated with 0.5ml of BAU-DPV vaccine gave the highest mean PHA titre after primary and booster vaccination and the protection rate was also very good i.e. 100%. Thus it may Reed, L.J. and H. Muench, 1938 . A simple method of be concluded that 0.5 ml BAU-DPV vaccine was relatively better than 1.0 ml. BAU-DPV, 0.5 ml and 1.0 ml DLS-DPV vaccine.
